In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment
The transaction as well as the open offer is expected to be completed by June this year.
Cobas infinity edge is designed as an open platform, allowing healthcare professionals to easily access and adopt third-party innovators’ new digital tools and medically-relevant applications via the Roche digital marketplace
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
Subscribe To Our Newsletter & Stay Updated
